2-FMA

2-FMA
Chemical Nomenclature
Common names	2-FMA
Substitutive name	2-Fluoromethamphetamine
Systematic name	1-(2-Fluorophenyl)-N-methylpropan-2-amine
Class Membership
Psychoactive class	Stimulant
Chemical class	Amphetamine
Routes of Administration
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section. ⇣ Oral Dosage Threshold 5 mg Light 5 - 15 mg Common 15 - 30 mg Strong 30 - 50 mg Heavy 50 mg + Duration Total 7 - 9 hours Onset 30 - 60 minutes Come up 15 - 40 minutes Peak 2.5 - 4 hours Offset 2 - 3 hours After effects 4 - 12 hours ⇣ Insufflated Dosage Threshold 5 mg Light 5 - 15 mg Common 15 - 30 mg Strong 30 - 50 mg Heavy 50 mg + Duration Total 4 - 6 hours Onset 20 - 40 minutes Come up 10 - 20 minutes Peak 1 - 3 hours Offset 1.5 - 3 hours After effects 2 - 4 hours DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.
Interactions
Alcohol
GHB
GBL
Opioids
Cannabis
Caffeine
Ketamine
Methoxetamine
Psychedelics
Cocaine
DXM
PCP
25x-NBOMe
2C-T-x
5-MeO-xxT
DOx
Tramadol
aMT
MAOIs

This article is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it.

2-Fluoromethamphetamine (2-FMA) is a stimulant drug from the amphetamine family which is rarely found on the streets but commonly sold as a grey area research chemical through online vendors.

Subjective effects

Physical effects

• Stimulation
• Tactile enhancement
• Physical euphoria
• Dehydration
• Appetite suppression

Cognitive effects

• Thought acceleration
• Focus enhancement
• Wakefulness
• Information processing enhancement
• Motivation enhancement

Toxicity and Harm Potential

The toxicity and long term health effects of recreational 2-FMA use does not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 2-FMA is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychedelic community who have tried 2-FMA suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

Tolerance and Addiction Potential

Tolerance develops rapidly with repeated usage, so periods of extended use require increasing doses of the drug in order to achieve the same effect. Addiction is a serious risk with heavy recreational use of any substituted amphetamine.

Psychosis

Abuse of amphetamines can result in a stimulant psychosis that may present with a variety of symptoms (e.g., paranoia, hallucinations, delusions). A Cochrane Collaboration review on treatment for amphetamine, dextroamphetamine, and methamphetamine abuse-induced psychosis states that about 5–15% of users fail to recover completely. The same review asserts that, based upon at least one trial, antipsychotic medications effectively resolve the symptoms of acute amphetamine psychosis. Psychosis very rarely arises from therapeutic use.

See Also

• stimulants
• amphetamine
• methamphetamine